HCW Biologics 根据和解协议于2026年5月26日全额付清欠付Eirgenix的款项 - SEC文件披露

美股速递
Jul 01

根据向美国证券交易委员会(SEC)提交的文件,HCW Biologics Inc. 已于2026年5月26日,依据双方达成的和解协议,全额支付了其欠付Eirgenix的所有款项。此举标志着两家公司之间相关财务义务的完结。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10